reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

Recruiting N/A Interventional Study
Stimulant Use Disorder People Living With HIV
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Male
Study type
Interventional
Purpose
Treatment
Participants needed
260 (estimated)
Sponsor
University of Miami · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Assigned male sex at birth and has not undergone any transgender hormonal treatment 2. Reports having had sex with a male in the past 12 months 3. Age 18 or older 4. Is affiliated with a study referral source (e.g., AHF clinic, registry, other healthcare program or clinic) or…
Contacts

Jose Szapocznik, PhD

(305) 6105723

jszapocz@miami.edu

CONTACT